Growing international travel is fueling the Yellow Fever Vaccine Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Yellow Fever Vaccine Market Across 2026–2030?

The yellow fever vaccine market has demonstrated consistent growth in recent years. It is anticipated to increase from $4.74 billion in 2025 to $4.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this historical growth include recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, and public health initiatives.

The yellow fever vaccine market is projected to experience consistent expansion in the coming years, with its size anticipated to reach $5.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. This growth during the forecast period is attributable to factors such as climate-driven mosquito spread, increasing global travel, the expansion of vaccination infrastructure, higher funding allocated for disease prevention, and stronger outbreak preparedness. Significant trends expected in the forecast period include the broadening of routine immunization programs, a rising demand from international travelers, an increase in government-led vaccination campaigns, the growing use of single-dose vaccines, and an intensified focus on endemic disease prevention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Which Market Drivers Are Supporting The Expansion Of The Yellow Fever Vaccine Market?

The steady rise in international travel is anticipated to stimulate the future growth of the yellow fever vaccine market. International travel denotes the passage of individuals across national boundaries for recreational, commercial, or private objectives. This increase in international travel stems from heightened global movement, which is further bolstered by global economic recovery and the relaxation of post-pandemic travel restrictions. The yellow fever vaccine market assists travelers by offering either mandatory or suggested immunizations for access to areas where yellow fever is prevalent. For example, in January 2024, the World Tourism Organization (UNWTO), an international tourism agency located in Spain, reported that global international tourist arrivals reached 1.286 billion in 2023, an increase from 0.96 billion in 2022, marking a year-on-year rise of 0.326 billion international tourists. Consequently, the expansion of international travel is a key factor propelling the growth of the yellow fever vaccine market.

What Segmentation Levels Are Considered In The Yellow Fever Vaccine Market?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Application: Routine Immunization, Travelers, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Trends Are Projected To Affect The Yellow Fever Vaccine Market?

Leading companies within the yellow fever vaccine market are progressively concentrating on creating novel solutions, including T-cell adaptive booster vaccines. This effort aims to boost long-lasting immunity, enhance vaccine effectiveness, and overcome the drawbacks associated with conventional live-attenuated vaccines. T-cell adaptive booster vaccines are formulated to bolster the immune system by specifically amplifying T-cell responses. These responses enable the body to identify and combat infections with greater efficiency than older, antibody-centric vaccines. As an illustration, in April 2025, the All India Institute of Medical Sciences, a healthcare institution located in India, initiated Yellow Fever Vaccination services. This service offers travelers defense against the mosquito-borne viral illness and provides the globally recognized vaccination certificate. The objective of this program is to broaden access to the vaccine within Telangana, thereby lessening the necessity for individuals to travel extensively to alternative authorized facilities. Furthermore, the program guarantees compliance with international health regulations through its provision of safe administration under professional medical oversight, especially benefiting those with specific medical contraindications.

Which Leading Firms Are Contributing To The Growth Of The Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Read the full yellow fever vaccine market report here:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

How Is The Yellow Fever Vaccine Market Distributed Across Key Geographic Regions?

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Yellow Fever Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795